Deuterated compounds and uses thereof
US11459300B2 · kind B2 · utility
9Cited by
54References
20Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 19, 2021 |
| Grant date | Oct 4, 2022 |
| Priority date | — |
| Expiry date | May 19, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/05
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.